Hair-raising research leads to new approach to therapy
Using liposome-based technology, it may soon be possible to reduce hair loss in patients with cancer who are receiving antineoplastic therapy. It appears that a recently discovered liposome delivery method can accurately target hair matrix cells, and possibly follicle stem cells. It is possible to encapsulate drugs or genes inside these liposomes for direct delivery to the hair cells. The good tolerability profile of this approach is one of its key advantages over other gene delivery methods. Now, researchers need to test relevant drugs with this new technique to establish its efficacy against various types of alopecia.